Despite down-to-the-wire negotiations, the odds are that parts of the U.S. government will shut down at midnight Sept. 30, as ...

Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is ...

The U.S. FDA’s early alert program has communicated a number of potential device malfunction episodes since its inception in ...

Ernst & Young LLP didn't quite declare the patient cured but saw signs of a strong med-tech recovery after a few years on life support in its annual Pulse of the MedTech Industry report. The global ...

Palmetto GBA, the Medicare administrative contractor for most of the southeastern U.S., has opened a coverage analysis for ...

Opus Genetics Inc. will be sitting down with the U.S. FDA to talk about positive three-month data from the pediatric cohort ...

Anaptysbio Inc. said it intends to split into two publicly traded companies – one for developing a pipeline, the other for ...

Novo Nordisk A/S terminated its global licensing deal with Japan’s Heartseed Inc. for its allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocytes.

Two independent studies applied CRISPR-based genetic editing – one to treat leukemia and the other to target myeloma – to overcome the challenges faced by CAR T cells, such as exhaustion, impaired ...

Climb Bio Inc. has announced results from a completed nonhuman primate (NHP) study of CLYM-116, an anti-APRIL monoclonal ...

Orexo AB’s subsidiary Orexo US Inc. has been awarded $8 million in funding by the U.S. Biomedical Advanced Research and ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuray, Aidoc Medical, Alcon, Holberg EEG, Labcorp, Natus, Reflow Medical, Relief ...